SPON2 and posterior cortical atrophy: Based on the AUCs and their 95% CI and P values, ROC curves for serum SPON2 and PSA suggested that SPON2 can differentiate PCa patients with serum PSA≤10 ng/ml from healthy, elderly controls and that PSA cannot.